Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.

Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history now shows a revision tag updated from v3.6.2 to v3.6.3, indicating a minor software update to the page.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page history shows a software release update from v3.6.0 to v3.6.2, indicating a platform version change rather than data changes to the study record.SummaryDifference0.1%

- Check34 days agoChange DetectedAdditions show that no longer looking for participants and the record revision updated to v3.6.0; Deletion removes the previous revision v3.5.5 from the history.SummaryDifference0.4%

- Check41 days agoChange DetectedRevision tag in the page footer updated from v3.5.4 to v3.5.5, signaling a new site release version. This update is metadata-related and does not modify the study record content.SummaryDifference0.1%

- Check62 days agoChange DetectedA new Revision tag v3.5.4 appears, replacing the previous revision tag v3.5.3 as part of the site's release notes.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page footer now shows Revision: v3.5.3 instead of v3.5.2, indicating a new release/version of the ClinicalTrials.gov site. This update does not modify the study data or visible content on the page.SummaryDifference0.1%

Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.